RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

GPTHEALTH · GPT Healthcare Ltd · Healthcare Facilities

GPTHEALTH · GPT Healthcare Ltd · Healthcare Facilities

₹143.94+2.1%

As of 05 Nov close

52-week range

52wk low ₹11552wk high ₹175

17.7% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Revenue (latest Q)

₹126 Cr

Revenue YoY

PAT YoY

+65.7%

Operating margin

Revenue, last 8 quarters

Source: Yahoo Finance, as of 30 Jun 2026

P/E (TTM)

P/B

4.9

P/S (TTM)

2.7

Sector P/E

29.7

Dividend yield

+1.6%

Source: Yahoo Finance, as of 29 Oct 2026

CompanyP/EP/BNet marginROED/EDiv. yield
GPTHEALTH (this stock)25.84.9+9.6%+15.7%0.34+1.6%
Apollo Hospitals Enterprise64.913.4+7.8%+21.9%53.8+0.2%
Max Healthcare Institute71.59.9+17.2%+14.3%27.71+0.2%
Fortis Healthcare6914.6+11.0%+10.6%0.35+0.1%

Promoter

stable

FII

rising 2q

MF

4.65% (-0.04pp)

stable

Insider trades

No insider trades in the last 12 months.

Bulk/block deals

No bulk/block deals in the last 12 months.

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptPositive07 Aug 2026
View source filing →

Key takeaway: During the earnings conference call for Q1 FY27, management reported an 18.2% increase in total income and a 66% rise in profit after tax compared to the previous year. The network occupancy was at 45.5%, with an average revenue per occupied bed (ARPOB) of INR 42,350. Mature hospitals maintained a healthy occupancy of 58.07%, while the newly commissioned Raipur facility showed improvement. Management highlighted the growing demand for specialized tertiary care and the importance of advanced medical technologies. The company is focused on expanding its network, with plans for a new hospital in Jamshedpur and evaluating opportunities for a seventh hospital. Management set a goal of achieving long-term return on equity (ROE) and return on capital employed (ROCE) of around 25%. The call concluded with management expressing confidence in creating sustainable long-term value for stakeholders.

Management emphasized strong financial performance and growth opportunities.

Sourced from an exchange-filed transcript, dated 07 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive03 Aug 2026
View source filing →

Key takeaway: GPT Healthcare Limited submitted an investor presentation detailing its un-audited financial results for the first quarter ended June 30, 2026. The presentation highlighted a healthy operational performance, with an average revenue per occupied bed (ARPOB) of ₹42,350, driven by improved clinical mix and operating efficiencies. Network occupancy was reported at 45.5%, with mature hospitals showing resilient performance. The company emphasized its leadership in robotic-assisted surgery and expansion in oncology services. Financially, revenue from operations reached ₹126.2 crore, marking a 17.8% year-on-year increase, while profit after tax (PAT) was ₹12.7 crore, reflecting a 65.7% increase year-on-year. The company outlined its strategy to maintain occupancy around 70% and expand its bed capacity to over 1,000 beds within two years, aiming for a long-term return on capital employed (ROCE) of approximately 25%.

Management reported strong operational and financial performance in the first quarter.

Sourced from an exchange-filed presentation, dated 03 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptNeutral22 May 2026
View source filing →

Key takeaway: During the earnings call for Q4 FY '26, management provided an overview of GPT Healthcare Limited's operational and financial performance. Management highlighted the strong structural growth in India's healthcare sector, driven by rising health awareness and increasing demand for advanced tertiary care services. The average revenue per occupied bed (ARPOB) increased from INR 37,000 to INR 39,200, with network occupancy rising to 55.9%. The Salt Lake Hospital reported improved occupancy and ARPOB, while the newly commissioned Raipur Hospital achieved 14% occupancy. For FY '26, revenue from operations was INR 478.5 crores, with an EBITDA margin of 18.8%. Management noted that the Raipur facility had a negative EBITDA impact but anticipated gradual improvement. The company set a goal of adding 150 beds through the Jamshedpur hospital and guided toward an 8% growth in ARPOB for FY '27. Overall, management emphasized a focus on sustainable growth and improving operational efficiency.

Management presented a balanced view of operational performance and future goals.

Sourced from an exchange-filed transcript, dated 22 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationNeutral18 May 2026
View source filing →

Key takeaway: GPT Healthcare Limited submitted an investor presentation detailing its audited financial results for the fourth quarter and fiscal year ending March 31, 2026. The presentation highlighted an increase in Average Revenue Per Occupied Bed (ARPOB) to ₹39,243 from ₹37,180 in FY25, driven by improved clinical mix and operational efficiencies. The company reported total revenue of ₹478.5 crore and a Profit After Tax (PAT) of ₹42.2 crore for FY26. The new hospital in Raipur negatively impacted overall EBITDA, which was ₹90.1 crore, with a margin of 18.84%. Mature hospitals maintained a healthy occupancy rate of 55.90%, while the Raipur hospital's occupancy was significantly lower at 12.35%. The company emphasized its focus on expanding its network and enhancing clinical capabilities, with plans to scale to a 1,000+ bed network. The presentation also noted the recovery of the Bangladesh patient segment and ongoing projects aimed at improving asset productivity.

The presentation provided a balanced overview of financial performance and strategic initiatives without strong positive or negative emphasis.

Sourced from an exchange-filed presentation, dated 18 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive06 Feb 2026
View source filing →

Key takeaway: Management provided an overview of GPT Healthcare Limited's performance for the third quarter and nine months ending December 31, 2025, highlighting a stable operating performance with an EBITDA of INR 65.1 crores and a profit after tax of INR 27.6 crores. Revenue from operations reached INR 350.5 crores, reflecting a year-on-year growth of 12.12%. The average revenue per occupied bed stood at INR 38,797, with overall bed occupancy improving to 55%. Management noted strong performances from various hospitals, including Salt Lake and Agartala, and discussed ongoing investments in technology and new services. The company aims to build a 1,000-bedded hospital chain by 2027, focusing on expanding access to quality healthcare in Eastern India. Management also addressed challenges and strategies for improving occupancy rates and operational efficiency across its facilities.

Management emphasized growth and operational improvements across various hospitals.

Sourced from an exchange-filed transcript, dated 06 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2025-26184 pages

GPT Healthcare Limited (GPTHEALTH) reported FY2025-26 results with a focus on strategic expansion in underserved regions, including Raipur and Jharkhand. The company declared an interim dividend of ₹1.00 per share and a final dividend of ₹1.50 per share, totaling ₹2.50 per share. The company is exploring options to increase bed capacity to 1,000 beds in the next 1-2 years. The financial statements were prepared in accordance with Indian Accounting Standards, and the auditor confirmed the adequacy of internal financial controls. No material defaults, regulatory actions, or liquidity issues were reported.

  • Declared total dividend of ₹2.50 per share for FY2025-26.
  • Exploring expansion to 1,000 beds in eastern India within 1-2 years.
  • No material defaults, regulatory actions, or liquidity issues reported.
  • Internal financial controls were confirmed as adequate by the auditor.
  • Financial statements prepared under Indian Accounting Standards.

Key takeaway: GPT Healthcare Limited demonstrated strong strategic growth with no significant financial or regulatory risks, supported by adequate internal controls and a clear expansion plan.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 09 Jul 2026View source filing →

Governance disclosures

AI-generated

Needs attention

No item of a kind that needs attention was stored for this company.

Contingent Liability

3 occurrences

Recent (last 12 months)

Annual Report09 Jul 2026 (FY2025-26)
View source filing →

The company has a contingent liability related to an income tax matter where the Income Tax Department has issued assessment/reassessment orders disallowing certain expenses. The company has not made a provision for this in the financial statements.

Earlier (1-3 years ago)

Annual Report12 Jul 2025 (FY2024-25)
View source filing →

The company has contingent liabilities including bank guarantees and letters of credit outstanding as of March 31, 2025 and 2024.

Annual Report01 Jul 2024 (FY2023-24)
View source filing →

The company has a contingent liability of ₹918.82 lakhs from corporate guarantees provided to HDFC Bank as of 31 March 2024.

Related-Party Transaction

2 occurrences

Recent (last 12 months)

Annual Report09 Jul 2026 (FY2025-26)· 3 passages
View source filing →

The company has disclosed related party transactions involving several directors and relatives of key management personnel, including transactions with entities like GPT Sons Private Limited, the holding company, and payments related to doctors' payouts.

Earlier (1-3 years ago)

Annual Report12 Jul 2025 (FY2024-25)· 2 passages
View source filing →

The company has disclosed related-party transactions involving payments to relatives of directors and key management personnel, including doctors' payouts and dividend payments.

Open full Signal Dashboard →